nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—PLK1—uterine cervix—vulva cancer	0.0213	0.0213	CbGeAlD
Ruxolitinib—PLK1—mammalian vulva—vulva cancer	0.0186	0.0186	CbGeAlD
Ruxolitinib—CAMK1—uterine cervix—vulva cancer	0.0166	0.0166	CbGeAlD
Ruxolitinib—PLK3—urethra—vulva cancer	0.0163	0.0163	CbGeAlD
Ruxolitinib—PLK3—mammalian vulva—vulva cancer	0.0156	0.0156	CbGeAlD
Ruxolitinib—CAMK1—urethra—vulva cancer	0.0153	0.0153	CbGeAlD
Ruxolitinib—CAMK1—mammalian vulva—vulva cancer	0.0145	0.0145	CbGeAlD
Ruxolitinib—JAK1—epithelium—vulva cancer	0.0138	0.0138	CbGeAlD
Ruxolitinib—TAOK2—urethra—vulva cancer	0.0137	0.0137	CbGeAlD
Ruxolitinib—DCLK3—vagina—vulva cancer	0.0137	0.0137	CbGeAlD
Ruxolitinib—JAK1—uterine cervix—vulva cancer	0.0136	0.0136	CbGeAlD
Ruxolitinib—DCLK1—uterine cervix—vulva cancer	0.0136	0.0136	CbGeAlD
Ruxolitinib—DAPK2—uterine cervix—vulva cancer	0.013	0.013	CbGeAlD
Ruxolitinib—JAK1—urethra—vulva cancer	0.0125	0.0125	CbGeAlD
Ruxolitinib—DCLK1—urethra—vulva cancer	0.0125	0.0125	CbGeAlD
Ruxolitinib—CAMK1D—urethra—vulva cancer	0.0122	0.0122	CbGeAlD
Ruxolitinib—CLK2—uterine cervix—vulva cancer	0.0121	0.0121	CbGeAlD
Ruxolitinib—PLK3—vagina—vulva cancer	0.012	0.012	CbGeAlD
Ruxolitinib—DAPK2—urethra—vulva cancer	0.012	0.012	CbGeAlD
Ruxolitinib—JAK1—mammalian vulva—vulva cancer	0.0119	0.0119	CbGeAlD
Ruxolitinib—DCLK1—mammalian vulva—vulva cancer	0.0119	0.0119	CbGeAlD
Ruxolitinib—ROCK1—epithelium—vulva cancer	0.0118	0.0118	CbGeAlD
Ruxolitinib—CAMK1D—mammalian vulva—vulva cancer	0.0116	0.0116	CbGeAlD
Ruxolitinib—DAPK2—mammalian vulva—vulva cancer	0.0114	0.0114	CbGeAlD
Ruxolitinib—CAMK1—vagina—vulva cancer	0.0113	0.0113	CbGeAlD
Ruxolitinib—DAPK3—urethra—vulva cancer	0.0112	0.0112	CbGeAlD
Ruxolitinib—CLK2—urethra—vulva cancer	0.0111	0.0111	CbGeAlD
Ruxolitinib—NUAK2—uterine cervix—vulva cancer	0.0109	0.0109	CbGeAlD
Ruxolitinib—DAPK3—mammalian vulva—vulva cancer	0.0107	0.0107	CbGeAlD
Ruxolitinib—CLK2—mammalian vulva—vulva cancer	0.0106	0.0106	CbGeAlD
Ruxolitinib—BMPR2—urethra—vulva cancer	0.0105	0.0105	CbGeAlD
Ruxolitinib—CAMK2G—uterine cervix—vulva cancer	0.0102	0.0102	CbGeAlD
Ruxolitinib—BMP2K—uterine cervix—vulva cancer	0.0102	0.0102	CbGeAlD
Ruxolitinib—TAOK2—vagina—vulva cancer	0.0101	0.0101	CbGeAlD
Ruxolitinib—LRRK2—uterine cervix—vulva cancer	0.0101	0.0101	CbGeAlD
Ruxolitinib—PRKCE—lymph node—vulva cancer	0.00972	0.00972	CbGeAlD
Ruxolitinib—NUAK2—mammalian vulva—vulva cancer	0.00954	0.00954	CbGeAlD
Ruxolitinib—CAMK2G—urethra—vulva cancer	0.00938	0.00938	CbGeAlD
Ruxolitinib—PLK1—lymph node—vulva cancer	0.00934	0.00934	CbGeAlD
Ruxolitinib—RPS6KA6—lymph node—vulva cancer	0.00934	0.00934	CbGeAlD
Ruxolitinib—LRRK2—urethra—vulva cancer	0.0093	0.0093	CbGeAlD
Ruxolitinib—MAP3K2—uterine cervix—vulva cancer	0.00927	0.00927	CbGeAlD
Ruxolitinib—DCLK1—vagina—vulva cancer	0.00924	0.00924	CbGeAlD
Ruxolitinib—JAK1—vagina—vulva cancer	0.00924	0.00924	CbGeAlD
Ruxolitinib—MAP3K7—uterine cervix—vulva cancer	0.00919	0.00919	CbGeAlD
Ruxolitinib—CAMK1D—vagina—vulva cancer	0.00902	0.00902	CbGeAlD
Ruxolitinib—TYK2—uterine cervix—vulva cancer	0.00902	0.00902	CbGeAlD
Ruxolitinib—MKNK2—epithelium—vulva cancer	0.00898	0.00898	CbGeAlD
Ruxolitinib—IRAK1—uterine cervix—vulva cancer	0.0089	0.0089	CbGeAlD
Ruxolitinib—MKNK2—uterine cervix—vulva cancer	0.0089	0.0089	CbGeAlD
Ruxolitinib—LRRK2—mammalian vulva—vulva cancer	0.00885	0.00885	CbGeAlD
Ruxolitinib—DAPK2—vagina—vulva cancer	0.00882	0.00882	CbGeAlD
Ruxolitinib—RET—epithelium—vulva cancer	0.00876	0.00876	CbGeAlD
Ruxolitinib—STK16—vagina—vulva cancer	0.00868	0.00868	CbGeAlD
Ruxolitinib—MAP3K7—urethra—vulva cancer	0.00844	0.00844	CbGeAlD
Ruxolitinib—DAPK3—vagina—vulva cancer	0.00829	0.00829	CbGeAlD
Ruxolitinib—TYK2—urethra—vulva cancer	0.00829	0.00829	CbGeAlD
Ruxolitinib—JAK2—epithelium—vulva cancer	0.00828	0.00828	CbGeAlD
Ruxolitinib—CLK2—vagina—vulva cancer	0.00821	0.00821	CbGeAlD
Ruxolitinib—JAK2—uterine cervix—vulva cancer	0.00821	0.00821	CbGeAlD
Ruxolitinib—MKNK2—urethra—vulva cancer	0.00818	0.00818	CbGeAlD
Ruxolitinib—MAP3K7—mammalian vulva—vulva cancer	0.00804	0.00804	CbGeAlD
Ruxolitinib—MAP3K3—uterine cervix—vulva cancer	0.00791	0.00791	CbGeAlD
Ruxolitinib—TYK2—mammalian vulva—vulva cancer	0.00789	0.00789	CbGeAlD
Ruxolitinib—PLK3—lymph node—vulva cancer	0.00779	0.00779	CbGeAlD
Ruxolitinib—MKNK2—mammalian vulva—vulva cancer	0.00779	0.00779	CbGeAlD
Ruxolitinib—IRAK1—mammalian vulva—vulva cancer	0.00779	0.00779	CbGeAlD
Ruxolitinib—BMPR2—vagina—vulva cancer	0.00773	0.00773	CbGeAlD
Ruxolitinib—JAK2—urethra—vulva cancer	0.00754	0.00754	CbGeAlD
Ruxolitinib—LTK—lymph node—vulva cancer	0.00753	0.00753	CbGeAlD
Ruxolitinib—NUAK2—vagina—vulva cancer	0.00739	0.00739	CbGeAlD
Ruxolitinib—CAMK1—lymph node—vulva cancer	0.00729	0.00729	CbGeAlD
Ruxolitinib—MAP3K3—urethra—vulva cancer	0.00727	0.00727	CbGeAlD
Ruxolitinib—TAOK3—uterine cervix—vulva cancer	0.00721	0.00721	CbGeAlD
Ruxolitinib—JAK2—mammalian vulva—vulva cancer	0.00718	0.00718	CbGeAlD
Ruxolitinib—MARK2—lymph node—vulva cancer	0.00708	0.00708	CbGeAlD
Ruxolitinib—MAP3K3—mammalian vulva—vulva cancer	0.00692	0.00692	CbGeAlD
Ruxolitinib—BMP2K—vagina—vulva cancer	0.00692	0.00692	CbGeAlD
Ruxolitinib—CAMK2G—vagina—vulva cancer	0.00692	0.00692	CbGeAlD
Ruxolitinib—LRRK2—vagina—vulva cancer	0.00686	0.00686	CbGeAlD
Ruxolitinib—TAOK3—urethra—vulva cancer	0.00663	0.00663	CbGeAlD
Ruxolitinib—TAOK2—lymph node—vulva cancer	0.00655	0.00655	CbGeAlD
Ruxolitinib—TAOK3—mammalian vulva—vulva cancer	0.00631	0.00631	CbGeAlD
Ruxolitinib—MAP3K7—vagina—vulva cancer	0.00622	0.00622	CbGeAlD
Ruxolitinib—TYK2—vagina—vulva cancer	0.00611	0.00611	CbGeAlD
Ruxolitinib—MKNK2—vagina—vulva cancer	0.00603	0.00603	CbGeAlD
Ruxolitinib—JAK3—lymph node—vulva cancer	0.00602	0.00602	CbGeAlD
Ruxolitinib—JAK1—lymph node—vulva cancer	0.00598	0.00598	CbGeAlD
Ruxolitinib—DCLK1—lymph node—vulva cancer	0.00598	0.00598	CbGeAlD
Ruxolitinib—PLK4—lymph node—vulva cancer	0.00594	0.00594	CbGeAlD
Ruxolitinib—CAMK1D—lymph node—vulva cancer	0.00584	0.00584	CbGeAlD
Ruxolitinib—PHKG2—lymph node—vulva cancer	0.0058	0.0058	CbGeAlD
Ruxolitinib—DAPK2—lymph node—vulva cancer	0.0057	0.0057	CbGeAlD
Ruxolitinib—STK16—lymph node—vulva cancer	0.00561	0.00561	CbGeAlD
Ruxolitinib—HIPK2—lymph node—vulva cancer	0.00558	0.00558	CbGeAlD
Ruxolitinib—JAK2—vagina—vulva cancer	0.00556	0.00556	CbGeAlD
Ruxolitinib—DAPK3—lymph node—vulva cancer	0.00536	0.00536	CbGeAlD
Ruxolitinib—MAP3K3—vagina—vulva cancer	0.00536	0.00536	CbGeAlD
Ruxolitinib—CLK2—lymph node—vulva cancer	0.00531	0.00531	CbGeAlD
Ruxolitinib—DYRK1A—lymph node—vulva cancer	0.00502	0.00502	CbGeAlD
Ruxolitinib—BMPR2—lymph node—vulva cancer	0.005	0.005	CbGeAlD
Ruxolitinib—TAOK3—vagina—vulva cancer	0.00489	0.00489	CbGeAlD
Ruxolitinib—NUAK2—lymph node—vulva cancer	0.00478	0.00478	CbGeAlD
Ruxolitinib—CAMK2G—lymph node—vulva cancer	0.00448	0.00448	CbGeAlD
Ruxolitinib—BMP2K—lymph node—vulva cancer	0.00448	0.00448	CbGeAlD
Ruxolitinib—LRRK2—lymph node—vulva cancer	0.00444	0.00444	CbGeAlD
Ruxolitinib—MAP3K2—lymph node—vulva cancer	0.00406	0.00406	CbGeAlD
Ruxolitinib—MAP3K7—lymph node—vulva cancer	0.00403	0.00403	CbGeAlD
Ruxolitinib—TYK2—lymph node—vulva cancer	0.00395	0.00395	CbGeAlD
Ruxolitinib—MKNK2—lymph node—vulva cancer	0.0039	0.0039	CbGeAlD
Ruxolitinib—IRAK1—lymph node—vulva cancer	0.0039	0.0039	CbGeAlD
Ruxolitinib—RET—lymph node—vulva cancer	0.00381	0.00381	CbGeAlD
Ruxolitinib—JAK2—lymph node—vulva cancer	0.0036	0.0036	CbGeAlD
Ruxolitinib—MAP3K3—lymph node—vulva cancer	0.00347	0.00347	CbGeAlD
Ruxolitinib—TAOK3—lymph node—vulva cancer	0.00316	0.00316	CbGeAlD
